Treatment‐related adverse events of antibody–drug conjugates in clinical trials: A systematic review and meta‐analysis

BACKGROUND: Antibody–drug conjugates (ADCs) have complex molecular structures and have been tested in numerous clinical trials. Therefore, understanding the mechanisms of their toxicity when applied in medical practice is of high importance. METHODS: In a systematic review and meta‐analysis of data...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Youwen, Liu, Kun, Wang, Kailing, Zhu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099922/
https://www.ncbi.nlm.nih.gov/pubmed/36408673
http://dx.doi.org/10.1002/cncr.34507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099922/
https://www.ncbi.nlm.nih.gov/pubmed/36408673
http://dx.doi.org/10.1002/cncr.34507

Ejemplares similares